EUVIMEDEUVIMED entdecken
Open Access

Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis

Pan Ma iD, Jing Liu iD, Juan Qin iD, Lulu Lai iD, Gyu Seong Heo iD, Hannah Luehmann, Deborah Sultan, Andrea Bredemeyer, Geetika Bajapa, Guoshuai Feng iD, Jesus Jimenez, Ruijun He und 9 weitere

Circulation · 02.01.2024 · 149 (1) · 48-66

DOI: 10.1161/circulationaha.122.062551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.01.2024. Verfasst von Pan Ma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Department of Medicine (P.M., J.L., A.B., G.B., G.F., J.J., R.H., A.P., J.A., K.J.L.), Washington University School of Medic…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Myocarditis. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Immune checkpoint inhibitors (ICIs), antibodies targeting PD-1 (programmed cell death protein 1)/PD-L1 (programmed death-ligand 1) or CTLA4 (cytotoxic T-lymphocyte–associated protein 4), have revolutionized cancer management but are associated with devastating immune-related adverse events including myocarditis. The main risk factor for ICI myocarditis is the use of combination PD-1 and CTLA4 inhibition. ICI myocarditis is often fulminant and is pathologically characterized by myocardial infiltration of T lymphocytes and macrophages. Although much has been learned about the role of T-cells in ICI myocarditis, little is understood about the identity, transcriptional diversity, and functions of infiltrating macrophages. METHODS: We used an established murine ICI myocarditis model ( Ctla4 +/– Pdcd1 –/– mice) to explore the cardiac immune landscape using single-cell RNA-sequencing, immunostaining, flow cytometry, in situ RNA hybridization, molecular imaging, and antibody neutralization studies. RESULTS: We observed marked increases in CCR2 (C-C chemokine receptor type 2) + monocyte-derived macrophages and CD8 + T-cells in this model. The macrophage compartment was heterogeneous and displayed marked enrichment in an inflammatory CCR2 + subpopulation highly expressing Cxcl9 (chemokine [C-X-C motif] ligand 9), Cxcl10 (chemokine [C-X-C motif] ligand 10), Gbp2b (interferon-induced guanylate-binding protein 2b), and Fcgr4 (Fc receptor, IgG, low affinity IV) that originated from CCR2 + monocytes. It is important that a similar macrophage population expressing CXCL9 , CXCL10 , and CD16α (human homologue of mouse FcgR4) was expanded in patients with ICI myocarditis. In silico prediction of cell-cell communication suggested interactions between T-cells and Cxcl9 + Cxcl10 + macrophages via IFN-γ (interferon gamma) and CXCR3 (CXC chemokine receptor 3) signaling pathways. Depleting CD8 + T-cells or macrophages and blockade of IFN-γ signaling blunted the expansion of Cxcl9 + Cxcl10 + macrophages in the heart and attenuated myocarditis, suggesting that this interaction was necessary for disease pathogenesis. CONCLUSIONS: These data demonstrate that ICI myocarditis is associated with the expansion of a specific population of IFN-γ–induced inflammatory macrophages and suggest the possibility that IFN-γ blockade may be considered as a treatment option for this devastating condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMyocarditisHumansMiceAnimalsCD8-Positive T-LymphocytesProgrammed Cell Death 1 ReceptorCTLA-4 AntigenLigandsChemokinesMacrophagesRNA

Stichwörter der Autor:innen

CXCL9 chemokineIFN-gammaT-cellscytotoxic T lymphocyte-associated antigen 4-immunoglobulinmacrophagesmyocarditisprogrammed cell death protein 1

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorCTLA-4 AntigenLigandsChemokinesRNA

Autor:innen und Institutionen

  • Cardiovascular Division, Department of Medicine (P.M., J.L., A.B., G.B., G.F., J.J., R.H., A.P., J.A., K.J.L.), Washington University School of Medicine, St Louis, MO.
  • Division of Cardiology, Department of Medicine, University of California San Francisco (J.Q., J.M.).
  • Department of Pathology and Immunology (L.L., A.V., C.-Y.L., K.J.L.), Washington University School of Medicine, St Louis, MO.
  • Mallinckrodt Institute of Radiology (G.S.H., H.L., D.S., Y.L.), Washington University School of Medicine, St Louis, MO.
  • Department of Internal Medicine II - Nephrology, Universitatsklinikum Regensburg Klinik und Poliklinik Innere Medizin II, Regensburg, Germany (M.M.).
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (K.A.).

ORCID-Profile: Pan Ma, Jing Liu, Juan Qin, Lulu Lai, Gyu Seong Heo, Guoshuai Feng, Antanisha Parks, Junedh Amrute, Ana Villanueva, Yongjian Liu, Chieh-Yu Lin, Kaushik Amancherla, Javid Moslehi, Kory J Lavine

Förderung

  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Ma, P., Liu, J., Qin, J., Lai, L., Heo, G. S., Luehmann, H., Sultan, D., Bredemeyer, A., Bajapa, G., Feng, G., Jimenez, J., He, R., Parks, A., Amrute, J., Villanueva, A., Liu, Y., Lin, C. Y., Mack, M., Amancherla, K., …, & Lavine, K. J. (2024). Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. Circulation, 149(1), 48-66. https://doi.org/10.1161/circulationaha.122.062551

Vancouver

Ma P, Liu J, Qin J, Lai L, Heo GS, Luehmann H, et al. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. Circulation. 2024;149(1):48-66. doi:10.1161/circulationaha.122.062551

BibTeX
@article{Ma2024,
  author = {Ma, Pan and Liu, Jing and Qin, Juan and Lai, Lulu and Heo, Gyu Seong and Luehmann, Hannah and Sultan, Deborah and Bredemeyer, Andrea and Bajapa, Geetika and Feng, Guoshuai and Jimenez, Jesus and He, Ruijun and Parks, Antanisha and Amrute, Junedh and Villanueva, Ana and Liu, Yongjian and Lin, Chieh-Yu and Mack, Matthias and Amancherla, Kaushik and Moslehi, Javid and Lavine, Kory J},
  title = {Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis},
  journal = {Circulation},
  year = {2024},
  volume = {149},
  number = {1},
  pages = {48--66},
  doi = {10.1161/circulationaha.122.062551}
}
Kostenlos starten →